Sriven Pharmachem India Private Limited - Company Profile

It is a pharma private limited company based in Tirumalagiri, Telangana, India, established in 2015.

2015 Tirumalagiri, Telangana, India Active

Last Updated: February 18, 2026

About Sriven Pharmachem India Private Limited

Sriven Pharmachem India Private Limited, a active private limited company, was established on 05 March 2015 in Tirumalagiri, Telangana, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24233TG2015PTC097894. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹31.00 Cr and a paid-up capital of ₹30.46 Cr.

It upholds a compliant status. Employing 79 professional, Its leadership includes Suryanarayana Raju Rudraraju (Director), Krishnaveni Rudraraju (Director), Raj Thirmal Mekamalla (Director). Past directors included Padmanabha Raju Chekuri, Mantena Kumar Naveen, Ramaraju Kanumuri. It holds ₹45.06 Cr open charges and ₹1.75 Cr settled loans. Its latest AGM occurred on 24 September 2025, with the balance sheet filed on 31 March 2025. It is based at H. No. 1-2-33/15, Plot No. 15 & 16, Flat No. 101,, A S R Raju Nagar, Road No. 1, Nizampet Road,, Tirumalagiri, Telangana, 500085.

Company Details

CIN/LLPIN
U24233TG2015PTC097894
Registration Number
097894
Incorporation Date
05 March 2015
Authorized Capital
₹31.00 Cr
Paid-Up Capital
₹30.46 Cr
ROC Code
Roc Hyderabad
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 31.00 Cr as on 18-02-2026
Paid Up Capital ₹ 30.46 Cr as on 18-02-2026
Company Age 11 Year, 12 Days
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 45.06 Cr as on 18-02-2026
Satisfied Charges ₹ 1.75 Cr as on 18-02-2026
Revenue Growth **** 112.69% (FY 2023)
Profit Growth **** 67.51% (FY 2023)
Ebitda **** 42.31% (FY 2023)
Net Worth 62.33% (FY 2023)
Total Assets **** 473.36% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Sriven Pharmachem India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Sriven Pharmachem India Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Suryanarayana Raju Rudraraju	Director	05 Mar 2015	Current
Krishnaveni Rudraraju	Director	08 Dec 2022	Current
Raj Thirmal Mekamalla	Director	21 Feb 2025	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	11 Aug 2017	Past
Pramod Abcsdd	Director	28 Dec 2019	Past
Pramod Abcsdd	Director	22 Jun 2020	Past
Pramod Abcsdd	Director	06 Jan 2017	Past
Pramod Abcsdd	Director	11 Aug 2017	Past
Pramod Abcsdd	Director	06 Jan 2017	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sriven Pharmachem India.

Sriven Pharmachem India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 112.69% increase. The company also saw a substantial improvement in profitability, with a 67.51% increase in profit. The company's net worth Soared by an impressive increase of 62.33%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

112.69%

*******

Revenue from Operations

*******

109.16%

*******

Total Assets

*******

473.36%

*******

Profit or Loss

*******

67.51%

*******

Net Worth

*******

62.33%

*******

EBITDA

*******

42.31%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sriven Pharmachem India?

In 2023, Sriven Pharmachem India had a public holding of 5.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹450,569,001.00

Satisfied Charges

₹17,500,000.00

Charges Breakdown by Lending Institutions

Hdfc Bank Limited : 41.17 Cr
Others : 1.90 Cr
Canara Bank : 1.40 Cr
Axis Bank Limited : 0.59 Cr

Latest Charge Details

Date	Lender	Amount	Status
14 Nov 2025	Others	₹0.93 M	Open
22 Sep 2025	Canara Bank	₹1.40 Cr	Open
14 Aug 2024	Hdfc Bank Limited	₹0.99 M	Open
26 Jul 2024	Hdfc Bank Limited	₹1.15 M	Open
16 Jul 2024	Others	₹1.01 M	Open

Explore comprehensive loan charge details -

How Many Employees Work at Sriven Pharmachem India?

Sriven Pharmachem India has a workforce of 79 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Sriven Pharmachem India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sriven Pharmachem India's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sriven Pharmachem India

Recent Activity within the Organization

Charges

A charge with Others amounted to Rs. 0.09 Cr with Charge ID 101197783 was registered on 14 Nov 2025. was recorded as a recent event.
14 Nov 2025
Annual General Meeting

Sriven Pharmachem India Private Limited last Annual general meeting of members was held on 24 Sep 2025 as per latest MCA records. was recorded as a recent event.
24 Sep 2025
Charges

The activity A charge with Canara Bank amounted to Rs. 1.40 Cr with Charge ID 101174560 was registered on 22 Sep 2025. was completed.
22 Sep 2025
Director Appointment

The activity Priyanka Gaur was appointed as a Company Secretary was appointed as a Company Secretary on 20 Jun 2025 & has been associated with this company since 8 months 26 days . was completed.
20 Jun 2025
Balance Sheet

Sriven Pharmachem India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was recorded as a recent event.
31 Mar 2025
Director Appointment

Raj Thirmal Mekamalla was appointed as a Director was appointed as a Director on 21 Feb 2025 & has been associated with this company since 1 year 23 days . was recorded as a recent event.
21 Feb 2025

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Sriven Pharmachem India Private Limited?

The CIN of Sriven Pharmachem India Private Limited is U24233TG2015PTC097894.

Where is Sriven Pharmachem India Private Limited headquartered?

Sriven Pharmachem India Private Limited is headquartered at H. No. 1-2-33/15, Plot No. 15 & 16, Flat No. 101,, A S R Raju Nagar, Road No. 1, Nizampet Road,, Tirumalagiri, Telangana, 500085.

When was Sriven Pharmachem India Private Limited incorporated?

Sriven Pharmachem India Private Limited was incorporated on 05 March 2015.

Who are the current directors of Sriven Pharmachem India Private Limited?

The current directors of Sriven Pharmachem India Private Limited are

What is the primary industry of Sriven Pharmachem India Private Limited?

The primary industry of Sriven Pharmachem India Private Limited is Manufacturing.

Is Sriven Pharmachem India Private Limited a listed company?

Sriven Pharmachem India Private Limited is unlisted.

What is the capital structure of Sriven Pharmachem India Private Limited?

The authorized capital of Sriven Pharmachem India Private Limited is ₹31.00 Cr, and the paid-up capital is ₹30.46 Cr.

What is the compliance status of Sriven Pharmachem India Private Limited?

The compliance status of Sriven Pharmachem India Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available